Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular System Injuries

NCT03631056 · Status: APPROVED_FOR_MARKETING · Type: EXPANDED_ACCESS

Last updated 2025-08-24

No results posted yet for this study

Summary

Individual patient expanded access requests may be considered for patients who have no other treatment options and are not eligible for an ATEV clinical study

Conditions

  • Vascular System Injuries

Interventions

BIOLOGICAL

Acellular Tissue Engineered Vessel (ATEV) / Human Acellular Vessel (HAV)

Sponsors & Collaborators

  • Humacyte, Inc.

    lead INDUSTRY

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03631056 on ClinicalTrials.gov